Cargando…
Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis
Bone targeted delivery of estrogen offers great promise for the clinical application of estrogen in the treatment of postmenopausal osteoporosis (PMOP). However, the current bone-targeted drug delivery system still has several issues that need to be solved, such as the side effects of bone-targeted...
Autores principales: | Chen, Zhong-Hua, Du, De-Yan, Fu, Yi-Fei, Wu, Jun-Jie, Guo, Dan-Yang, Li, Yue-Yue, Chen, Meng-Nan, Yuan, Zheng-Dong, Zhang, Kai-Wen, Zhang, Zhen-Yu, Li, Xia, Yuan, Feng-Lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415756/ https://www.ncbi.nlm.nih.gov/pubmed/37576873 http://dx.doi.org/10.1016/j.mtbio.2023.100747 |
Ejemplares similares
-
Novel one-pot strategy for fabrication of a pH-Responsive bone-targeted drug self-frame delivery system for treatment of osteoporosis()
por: Yang, Xinmin, et al.
Publicado: (2023) -
A ROS-responsive synergistic delivery system for combined immunotherapy and chemotherapy
por: Hu, Doudou, et al.
Publicado: (2022) -
Improved anti-hepatocellular carcinoma effect by enhanced Co-delivery of Tim-3 siRNA and sorafenib via multiple pH triggered drug-eluting nanoparticles
por: Song, Chenghua, et al.
Publicado: (2022) -
Enhanced tissue infiltration and bone regeneration through spatiotemporal delivery of bioactive factors from polyelectrolytes modified biomimetic scaffold
por: Zhou, Xiaojun, et al.
Publicado: (2023) -
N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis
por: Peng, Wan-Xin, et al.
Publicado: (2022)